This novel self‐assembling vaccine, 8FNs, can reverse the immunosuppressive microenvironment and elicit potent antitumor immunity by strengthening specific CD8+ T cell responses against local and metastatic tumors. The gene discussed is CD8A; the disease is metastatic neoplasm.